Nanosphere Ends Yearly Revenue up on Verigene Sales | GenomeWeb

This article has been updated to include additional Q4 financial information, comments from a conference call, and a stock quote.

NEW YORK (GenomeWeb News) – Nanosphere said on Thursday after the close of the market that its fourth-quarter revenues rose 66 percent, with all of its sales coming from its Verigene System.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.